{"id":15298,"date":"2025-08-29T15:03:27","date_gmt":"2025-08-29T15:03:27","guid":{"rendered":"https:\/\/investx.fr\/es\/?p=15298"},"modified":"2025-08-29T15:03:28","modified_gmt":"2025-08-29T15:03:28","slug":"reservas-corporativas-peligro-para-criptomoneda","status":"publish","type":"post","link":"https:\/\/investx.fr\/es\/noticias-cripto\/reservas-corporativas-peligro-para-criptomoneda\/","title":{"rendered":"\u00bfLas reservas corporativas: \u00bfUn peligro para la criptomoneda?"},"content":{"rendered":"\n

Compra de criptomoneda por empresas: \u00bfOportunidad o trampa para los inversores?<\/h2>\n\n\n\n

Las empresas cotizadas que anuncian una compra masiva en criptomoneda<\/a><\/strong> para sus reservas suelen ver c\u00f3mo sus acciones se disparan en los d\u00edas previos. Una tendencia que genera preocupaci\u00f3n<\/strong> por posibles casos de informaci\u00f3n privilegiada en un sector todav\u00eda muy poco regulado.<\/p>\n\n\n\n

\n

MEI Pharma became the first public US company to adopt a Litecoin Treasury Strategy.

929,548
$LTC<\/a> were acquired for ~$100M at ~$107.58 per token.

Thanks to the involvement of
@SatoshiLite<\/a> & @GSR_io<\/a>, we're bringing the people's currency to institutional portfolios.$MEIP<\/a> pic.twitter.com\/EuRDtfse8m<\/a><\/p>— MEI Pharma (@MEI_Pharma) August 14, 2025<\/a><\/blockquote>